Unique Approach

We take the time to build relationships with potential partners including individual inventors, academic and research institutions and life sciences companies. In so doing, we complete transactions tailored to each royalty recipient’s unique needs and circumstances.

Over our 32-year history, DRI has built and maintained a proprietary database of over 6,500 royalties on over 2,000 products that gives us significant market intelligence in identifying royalties to add to our portfolio and the inventors and institutions that own them.

Collectively, our professional team has over 150 years of combined experience. The team holds deep life sciences industry expertise drawn from a variety of disciplines including pharmaceutical, scientific, financial, healthcare, intellectual property and legal backgrounds. The breadth and depth of our team allows us to identify unique attractive opportunities for growth and conduct comprehensive due diligence on such investments.

Our vast experience in structuring royalty monetization transactions gives us a competitive advantage in working with royalty owners and intellectual property holders to devise deals that satisfy the objectives of all parties. We are able to provide bespoke solutions to our counterparties to create “win win” transactions.

Throughout our history, DRI has developed a sterling reputation with royalty sellers through our proven capability to execute on transactions, and with investors due to our ability to identify attractive opportunities to acquire assets accretively.